£100.49

It has never been this cheap. We have no record of a lower price.

£100 today · cheaper than every other day in the last 3 months

Springer Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series, 17)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 18 days · 18 data points (no recent data)

Historical
Generating forecast…
£100.49 £95.47 £97.48 £99.49 £101.49 £103.50 £105.51 26 July 2026 30 July 2026 03 August 2026 07 August 2026 12 August 2026
View at Amazon ↗

Price data last checked 73 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 18 days • 1 price levels

Days at Price
18 days 0 5 9 14 18 £100 Days at Price

Price Analysis

Most common price: £100 (18 days, 100.0%)

Price range: £100 - £100

Price levels: 1 different prices over 18 days

Description

The field of antibody-drug conjugates (ADCs) has undergone remarkable advancements in recent years, marked by significant progress in both drug approvals and ongoing clinical development. Since the approval of the first ADC in 2010 (gemtuzumab ozogamicin, Mylotarg®), the landscape has expanded dramatically. Today, there are 11 FDA-approved ADCs, targeting a variety of cancers across multiple indications. The approved ADCs include a range of payloads, linkers, and antibodies, each optimized for a variety of specific therapeutic targets. The increasing diversity of ADCs reflects the growing potential of these innovative treatments to address a wide array of malignancies, from hematologic cancers to solid tumors. This book aims to provide a comprehensive overview of the current state of the ADC field including the latest developments, challenges, and emerging trends, comprising expertise from a broad range of disciplines from basic research, industry, clinical practice and regulatory affairs. We explore not only the scientific and technical aspects of ADC design―such as payloads, linkers, and antibody selection―but also the developmental hurdles and regulatory complexities that influence the success of ADCs in clinical practice. Real-world examples of ADCs that have made it from the lab to the clinic offer invaluable insights into the trials and triumphs that shape this dynamic field. It is our hope that this book will serve as both a valuable resource for experts in the field and an accessible introduction for those new to the exciting world of ADCs.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
16 April 2025
Listed Since
10 December 2024

Barcode

No barcode data available

Similar Products You Might Like

Antibody-Drug Conjugates and Immunotoxins - Cancer Drug Discovery
98% match

Antibody-Drug Conjugates and Immunotoxins - Cancer Drug Discovery

Humana

£112.57 21 Oct 2026
Wiley A Beginner's Guide to Targeted Cancer Treatments
97% match

Wiley A Beginner's Guide to Targeted Cancer Treatments

Wiley

£44.89 26 Sep 2026
Innovations for Next-Generation Antibody-Drug Conjugates (Cancer Drug Discovery and Development)
97% match

Innovations for Next-Generation Antibody-Drug Conjugates (Cancer Drug Discovery and Development)

Humana

£111.33 23 Sep 2026
Immunotherapy in Translational Cancer Research (Translational Oncology)
97% match

Immunotherapy in Translational Cancer Research (Translational Oncology)

Wiley

£130.00 22 Aug 2026
Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)
96% match

Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)

Humana

£156.36 12 Aug 2026
Cancer Biotherapy: An Introductory Guide
96% match

Cancer Biotherapy: An Introductory Guide

Oxford University Press

£110.00 17 Oct 2026
Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)
96% match

Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)

Humana

£110.83 22 Sep 2026
Critical Developments in Cancer Immunotherapy
96% match

Critical Developments in Cancer Immunotherapy

£421.00 01 Oct 2026
Development and Approval of Combination Products: A Regulatory Perspective
96% match

Development and Approval of Combination Products: A Regulatory Perspective

Wiley

£73.31 07 Oct 2026
Humana Gene and Cellular Immunotherapy for Cancer Book
96% match

Humana Gene and Cellular Immunotherapy for Cancer Book

Humana

£106.78 04 Sep 2026
Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)
96% match

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Springer

£87.93 01 Oct 2026
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
96% match

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Humana

£69.37 22 Sep 2026
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
96% match

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Humana

£143.84 20 Aug 2026
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
96% match

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Humana

£148.21 24 Sep 2026
Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)
96% match

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Springer

£179.99 30 Sep 2026
Cancer Immunoprevention: Methods and Protocols: 2435 (Methods in Molecular Biology, 2435)
96% match

Cancer Immunoprevention: Methods and Protocols: 2435 (Methods in Molecular Biology, 2435)

Humana

£109.99 17 Sep 2026
Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies
96% match

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

Elsevier

£131.39 20 Aug 2026
Novel Immunotherapeutic Approaches to Cancer Treatment - Springer
96% match

Novel Immunotherapeutic Approaches to Cancer Treatment - Springer

Springer

£114.88 02 Oct 2026
Small Molecules for Cancer Treatment
96% match

Small Molecules for Cancer Treatment

Springer

£158.84 02 Sep 2026
Novel Immunotherapeutic Approaches to Cancer Treatment - Springer
96% match

Novel Immunotherapeutic Approaches to Cancer Treatment - Springer

Springer

£108.91 03 Oct 2026
Small Molecules in Hematology: 212 (Recent Results in Cancer Research, 212)
96% match

Small Molecules in Hematology: 212 (Recent Results in Cancer Research, 212)

Springer

£59.07 09 Oct 2026
Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)
96% match

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Springer

£144.92 20 Oct 2026
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
96% match

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Springer

£148.21 13 Oct 2026
Handbook of Targeted Cancer Therapy and Immunotherapy
96% match

Handbook of Targeted Cancer Therapy and Immunotherapy

WOLTERS KLUWER HEALTH

£54.01 10 Sep 2026